The Combination of Ezetimibe and Statin: A New Treatment for Hypercholesterolemia
Author:
Affiliation:
1. Section on Cardiovascular Diseases, Department of Experimental and Applied Medicine, University of Brescia - Italy
Publisher
Touch Medical Media, Ltd.
Subject
Cardiology and Cardiovascular Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/1826186807003001-202
Reference16 articles.
1. Results of the National Cholesterol Education (NCEP) Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE) II Survey and Implications for Treatment Under the Recent NCEP Writing Group Recommendations
2. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme
3. Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study
4. Cholesterol absorption inhibition: filling an unmet need in lipid-lowering management
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Strategic design and clinical evaluation of a fixed-dose combination tablet comprising valsartan, amlodipine, rosuvastatin and ezetimibe for patients with hypertension and dyslipidemia;Journal of Pharmaceutical Investigation;2023-12-20
2. Development of New Genome Editing Tools for the Treatment of Hyperlipidemia;Cells;2023-10-16
3. Statins and Their Effect on PCSK9—Impact and Clinical Relevance;Current Atherosclerosis Reports;2016-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3